NCT03500380 2024-02-20
A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
RemeGen Co., Ltd.
Phase 2/3 Unknown
Clinical Trials
30 trialsNCT04400695 2024-01-24
A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
RemeGen Co., Ltd.
Phase 3 Unknown
NCT04262804 2023-08-22
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
Zai Lab (Hong Kong), Ltd.
Phase 2 Unknown
NCT05845138 2023-08-01
A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2 Unknown
NCT05964543 2023-07-28
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
QureBio Ltd.
Phase 1/2 Unknown
NCT05799820 2023-05-25
QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC
Qilu Pharmaceutical Co., Ltd.
Phase 2 Unknown
NCT03613181 2023-04-24
ANGLeD
Angiochem Inc
Phase 3 Unknown
NCT03775525 2022-12-23
GEN602
Genzada Pharmaceuticals USA, Inc.
Phase 1 Unknown
NCT02973737 2022-10-25
A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT05235542 2022-08-11
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
Akeso
Phase 1/2 Unknown
NCT05344742 2022-04-25
A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
NCT04608786 2022-01-11
A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer
Lee's Pharmaceutical Limited
Phase 1 Unknown
NCT04802980 2021-07-28
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor
Huabo Biopharm Co., Ltd.
Phase 1 Unknown
NCT04809142 2021-03-22
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Unknown
NCT03080805 2020-06-18
Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT03873532 2020-02-13
A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients
Hutchmed
Phase 2/3 Unknown
NCT04185649 2019-12-04
The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Bio-Thera Solutions
Phase 3 Unknown
NCT04164615 2019-11-15
Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection
Genor Biopharma Co., Ltd.
Phase 3 Unknown
NCT03817411 2019-05-07
Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer
Taizhou EOC Pharma Co., Ltd.
Phase 2 Unknown
NCT03435666 2018-02-19
Capecitabine
Qilu Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT00049244 2017-01-30
BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer
R-Pharm
Phase 1 Unknown
NCT02854072 2016-11-22
A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients
Samsung Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT01315431 2012-07-24
A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors
Genta Incorporated
Phase 1 Unknown
NCT01573468 2012-07-24
TESEGAST
Genta Incorporated
Phase 2 Unknown
NCT00726687 2012-07-19
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
Alaunos Therapeutics
Phase 1/2 Unknown
NCT01231802 2012-07-17
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
Adherex Technologies, Inc.
Phase 2 Unknown
NCT01609127 2012-06-01
Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer
Genta Incorporated
Phase 2 Unknown
NCT01348009 2012-03-13
Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer
Genta Incorporated
Phase 1/2 Unknown
NCT00717951 2008-07-25
A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer
Academy Military Medical Science, China
Phase 2 Unknown
NCT00081536 2005-06-24
Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies
Aronex Pharmaceuticals
Phase 1/2 Unknown